Data from: Oral anticoagulation in patients with chronic kidney disease: a systematic review and meta-analysis

Konark Malhotra, Muhammad Fawad Ishfaq, Nitin Goyal, Aristeidis H. Katsanos, John Parissis, Anne W Alexandrov, Andrei V. Alexandrov & Georgios Tsivgoulis
Objective: Data regarding the efficacy and safety of warfarin and Non-Vitamin K Antagonist Oral Anticoagulant (NOAC) among patients with chronic kidney disease (CKD) remain scarce. Methods: Systematic review and meta-analysis of studies involving CKD patients treated on OACs was conducted to evaluate following outcomes: ischemic stroke, intracerebral hemorrhage (ICH), combined ischemic and hemorrhagic stroke (strokecombined), stroke or systemic embolism, mortality, and major bleeding events. CKD was defined based on creatinine clearance (CrCl) ranging from mild...
1 citation reported since publication in 2019.
374 views reported since publication in 2019.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
110 downloads reported since publication in 2019.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?